Samsung Adds Lunit AI to Radiography Solutions
Boston Imaging, the US headquarters of Samsung’s digital radiography (DR) and ultrasound business, announced that Samsung has signed a supply contract with Lunit Inc. to enable faster and more accurate chest screenings for timely interventions with improved patient outcomes.
The Lunit INSIGHT CXR, an AI-powered chest X-ray analysis solution, and Lunit Insight CXR Triage, an FDA 510(k)-cleared AI triage solution for critical chest ﬁndings, will enable Samsung’s CAD (Computer Aided Detection) AI to help radiologists manage the unprecedented volume of patient exams by prioritizing those with suspected abnormalities.
“Chest X-rays are still today the most requested exam in radiography,” said Eric Sumner, Head of Digital Radiography. “As part of our voice of customer initiatives, we are building on our prior oﬀering of auto lung nodule detection (ALND) by integrating new on-device, real-time artiﬁcial intelligence technologies. By partnering with Lunit, our Samsung digital radiology products will now have computer-assisted triage and notiﬁcation software that analyzes adult chest X-ray images for the presence of suspected pleural eﬀusion or pneumothorax. Patients with suspected ﬁndings will move to the top of the radiologist queue, allowing patients to be diagnosed more quickly. This will provide critical information to radiologists as they triage urgent cases.”
Over the past two years, Samsung has made signiﬁcant investments to bring best-in-class technology to radiology leaders and administration ensuring more enhanced patient care and workﬂow eﬃciency while maintaining a low-dose imaging experience.
“As advanced technologies deliver improved patient outcomes and cost savings in healthcare, our digital radiography ﬂagship products GM85 and GC85A Vision are at the forefront of that innovation, advancing healthcare imaging with features such as
“Vision Assist” and AccE Glass Free Detector,” said David Legg, Head of Boston Imaging. “With innovation as its cornerstone, Samsung continues to drive solutions to provide excellent patient experiences, simplify technologist workﬂows and aid in faster diagnosis. We are proud that the addition of Lunit’s AI-powered solutions will further radiologists’ abilities to provide eﬃcient and comprehensive patient care.”
The Lunit AI solution software is commercially available on Samsung digital radiology products as of Q1 2024, although the Lunit INSIGHT CXR has not received FDA 510(k) clearance. As part of the collaboration with Lunit, Samsung will continue to expand on validating the AI solution to detect the 10 most common abnormalities in Chest X-ray including nodule, pneumothorax, atelectasis, cardiomegaly, calciﬁcation, consolidation, pleural eﬀusion, pneumoperitoneum, mediastinal widening, ﬁbrosis and support tuberculosis screening.